JPH0256409A - Cosmetic containing bi-and trivalent iron salt blended therein - Google Patents
Cosmetic containing bi-and trivalent iron salt blended thereinInfo
- Publication number
- JPH0256409A JPH0256409A JP20789188A JP20789188A JPH0256409A JP H0256409 A JPH0256409 A JP H0256409A JP 20789188 A JP20789188 A JP 20789188A JP 20789188 A JP20789188 A JP 20789188A JP H0256409 A JPH0256409 A JP H0256409A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- trivalent iron
- cosmetics
- cosmetic
- iron salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 57
- 150000002505 iron Chemical class 0.000 title claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 abstract description 34
- 159000000014 iron salts Chemical class 0.000 abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 230000035790 physiological processes and functions Effects 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 5
- 230000037307 sensitive skin Effects 0.000 abstract description 5
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- 238000003912 environmental pollution Methods 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 230000004215 skin function Effects 0.000 abstract description 3
- 238000011109 contamination Methods 0.000 abstract description 2
- 239000002085 irritant Substances 0.000 abstract description 2
- 231100000021 irritant Toxicity 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000003248 secreting effect Effects 0.000 abstract description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract description 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 150000003841 chloride salts Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000007102 metabolic function Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 23
- 230000000694 effects Effects 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 17
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 229910017604 nitric acid Inorganic materials 0.000 description 11
- 239000008213 purified water Substances 0.000 description 11
- 239000003205 fragrance Substances 0.000 description 10
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 9
- 229910001431 copper ion Inorganic materials 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000007935 neutral effect Effects 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000037336 dry skin Effects 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000015961 tonic Nutrition 0.000 description 5
- 230000001256 tonic effect Effects 0.000 description 5
- 201000004384 Alopecia Diseases 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- -1 Polyoxyethylene monostearate Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 208000001840 Dandruff Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000008278 cosmetic cream Substances 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-N iron;hydrochloride Chemical compound Cl.[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000004037 social stress Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は生物活性作用、イオン化抑制作用、防腐作用な
ど生物学的に極めて興味ある作用を有する二価三価鉄塩
を配合した化粧品に関するものである。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to cosmetics containing divalent and trivalent iron salts that have extremely biologically interesting effects such as biologically active effects, ionization suppressing effects, and antiseptic effects. It is.
薬事法によると、化粧品とは「人の身体を清潔にし、美
化し、魅力を増し、容貌を変え、または皮膚若しくは毛
髪を健やかに保つために、身体に塗擦、散布その他これ
に類似する方法で使用されることが目的とされているも
のでるうて、人体に対する作用が緩和なもの」と規定さ
れているように、皮膚や毛髪の状伽を自然にあるいは人
工的に美しく整えるものである。そのために化粧水、乳
R,/IJ−ム、シャンフー、リンス、ヘアトニックあ
るいは口紅、ファンデージ曹ンなど非常に多種類の商品
が市販されている。さらに、各化粧品の効果tよシー層
明確化するために、各種保湿剤。According to the Pharmaceutical Affairs Law, cosmetics are defined as ``cosmetics that are applied by rubbing, spraying, or similar methods on the human body to cleanse, beautify, increase attractiveness, change appearance, or maintain healthy skin or hair. The product is intended to be used to naturally or artificially improve the appearance of the skin and hair, and is defined as having a mild effect on the human body. For this purpose, a wide variety of products are commercially available, such as lotions, milk creams, shampoos, conditioners, hair tonics, lipsticks, and foundation soaps. In addition, various moisturizers are used to clarify the effects of each cosmetic product.
油脂成分、界面活性剤、香料2色素類など天然物。Natural products such as oil and fat components, surfactants, fragrances, and pigments.
合成物原料が使用され、それぞれの配合成分によシ一応
O効果は得られている。Synthetic raw materials are used, and the O effect has been obtained to some extent depending on each compounded ingredient.
しかし、最近の環境汚染あるいは社会的なストレスの蓄
積から、皮膚本来の生理機能が衰えて、荒れ肌、乾燥肌
、敏感肌などのトラブル肌や、脱毛、白毛化など頭髪の
異常が非常に日立うてきている。このような状態におい
て、従来の化粧品を使用すると、更に皮膚の生理機能を
衰えさせる結果となって、そのための化粧品によるトラ
ブルが非常に増加してきている。However, due to recent environmental pollution and the accumulation of social stress, the natural physiological functions of the skin have deteriorated, resulting in problematic skin such as rough, dry, and sensitive skin, as well as hair abnormalities such as hair loss and graying. It's booming. If conventional cosmetics are used in such a condition, the physiological functions of the skin will further deteriorate, and the number of problems caused by cosmetics has increased significantly.
このような化粧品の突部からみて、皮膚本来の生理機能
を回復式せながら、しかも前記薬事法王の化粧品の定義
を十分く満足させる化粧品の開発が望まれている。この
問題を解決するには、従来から研究されてきている化粧
品の個々の配合成分による直接の効果だけでは寮現不可
能でめった。In view of these aspects of cosmetics, there is a desire to develop cosmetics that can restore the skin's natural physiological functions while also fully satisfying the definition of cosmetics set forth by the above-mentioned Pharmaceutical Affairs Pope. To solve this problem, it is rarely possible to solve this problem by relying solely on the direct effects of the individual ingredients of cosmetics, which have been studied to date.
例えば、乾燥した皮膚に水分を補給する目的のための保
湿剤ヒアルロン酸や水溶性蛋白質、またはシミ取シ、美
白のためのビタミンC誘導体など、ある程度の目的とす
る効果は達せられるが、実際には効果の持続性、あるい
に適用後の成分の変質による皮膚刺激性などの点で、種
々間稙が残されておシ、皮膚本来の生理機能の回復効果
を上けるまでKは至っていない。For example, moisturizers such as hyaluronic acid and water-soluble proteins to replenish moisture to dry skin, or vitamin C derivatives for spot removal and whitening, can achieve some desired effect, but in reality, However, there are still various problems with K, such as the durability of its effects and skin irritation due to deterioration of the ingredients after application, and K has not been able to improve the effect of restoring the skin's natural physiological functions. .
本発明者は、上記実情からみて、荒れ肌、敏感肌などの
トラブル肌にも安心して使用でき、しかも皮膚が本来持
つている防御機能、呼吸機能、排泄1分泌機能などの生
理機能を正常な伏動に回復させると七のできる化粧品に
関して鋭意研究を重ねた。その結果、特定の二価三価鉄
塩を配合した化粧品のみが、従来の化粧品の効能効果O
1忙、さらに皮膚機能の増進、再生能力の増強、環境汚
染などによる刺激物に対する抵抗力の強化、微生物汚染
の防止、有害イオン反応の阻止など、従来の化粧品には
望むべくもなかうた皮膚本来の正常な代廁機能を行わせ
ることが可能になることを見出した。In view of the above-mentioned circumstances, the present inventor has discovered that it can be used safely on troubled skin such as rough skin and sensitive skin, and that it can also be used to maintain normal physiological functions such as the skin's natural defense functions, respiratory function, and excretory and secretory functions. He has conducted extensive research on cosmetics that can help restore the body's health. As a result, only cosmetics containing specific divalent and trivalent iron salts have the efficacy and effectiveness of conventional cosmetics.
In addition, conventional cosmetics have the ability to improve skin function, enhance regenerative ability, strengthen resistance to irritants caused by environmental pollution, prevent microbial contamination, and inhibit harmful ionic reactions, which are impossible to achieve with conventional cosmetics. It has been found that it is possible to perform normal functions of the body.
即ち、本発明は上記の目的を持つ二価三価鉄塩を配合す
ることを特徴とする化粧品罠関するものである。That is, the present invention relates to a cosmetic trap characterized by containing a divalent and trivalent iron salt having the above-mentioned purpose.
以下、本発明について詳述する。The present invention will be explained in detail below.
本発明の化粧品に使用する二価三価鉄塩は、二価鉄塩と
二価鉄塩の中間の性質を示す鉄の塩酸塩。The divalent and trivalent iron salt used in the cosmetics of the present invention is an iron hydrochloride that exhibits intermediate properties between divalent iron salts and divalent iron salts.
硫酸塩、燐酸塩、硝酸塩などの無機塩類および蟻酸塩、
酢酸塩、プロピオン酸塩などの有機塩類がある。例えは
、公知のものとしてはF・8C4□・XH2O、F@5
CJ8”XH2Oなどの=価鉄と三価鉄の錯塩などが上
げられるが、本発明に最も好ましい二価三価鉄塩として
は、本筆頭発明者の特開昭59−190226号および
特開昭60−186581号に記載されているF@2C
J、・XH,Oが挙げられる。inorganic salts such as sulfates, phosphates, nitrates and formates;
There are organic salts such as acetate and propionate. For example, the known ones are F・8C4□・XH2O, F@5
Examples include complex salts of =valent iron and trivalent iron such as CJ8'' F@2C described in No. 60-186581
Examples include J, .XH, and O.
これら二価二価鉄塩は、水に溶解した場合、あるい4皮
膚表面表ど含水表面に塗擦した場合、各種イオン反応を
抑制することKよシ1通常の水系におけるイオン反応と
は著しく異なる反応を誘導すると思われ、本発明の=価
玉価鉄塩配合の化粧品を適用すれば、生体内の正規の非
イオン反応系が回復して、生体を正常な状【に復帰させ
ることができる。When these divalent iron salts are dissolved in water or rubbed on water-containing surfaces such as the skin surface, they suppress various ionic reactions. It is thought to induce a reaction, and by applying the cosmetics containing iron salts of the present invention, the normal non-ionic reaction system in the body can be restored and the body can be returned to its normal state. .
化粧品に上記二価三価鉄塩を配合する場合には、化粧品
の性状、配合剤の種類および目的効果に応じて、二価三
価鉄塩を単独で配合するはかシでなく、例えは塩化ナト
リウム、硫酸ナトリワム、塩化アンモニウム、硫酸アン
モニウム、塩化マグネシウム、珪藻土、ベントナイト、
シリカ、アルミナなどの無機物質、および植物性繊維、
パルプ。When blending the above divalent and trivalent iron salts into cosmetics, depending on the properties of the cosmetic, the type of compounding agent, and the intended effect, it is not advisable to blend the divalent and trivalent iron salts alone, but rather, for example, Sodium chloride, sodium sulfate, ammonium chloride, ammonium sulfate, magnesium chloride, diatomaceous earth, bentonite,
Inorganic substances such as silica and alumina, and vegetable fibers,
pulp.
ビタミン、ホルモン、蛋白質、脂質など有機物質を担体
として二価三価鉄塩を担持させて使用することが最も好
ましい。It is most preferable to use organic substances such as vitamins, hormones, proteins, and lipids as carriers to support the divalent and trivalent iron salts.
二価二価鉄塩の配合量4%担体も含めて、化粧&ll5
al 00 g当J> 1(r’−xr”gT6Js
好t L(F110’〜1r”gの範囲である。配合量
がこの範囲よシ多くても少なくても二価三価鉄塩の効果
は減弱される。Cosmetics &ll5 including the carrier with 4% divalent iron salt
al 00 gJ>1(r'-xr"gT6Js
Preferably, t L (F110' to 1r''g) is in the range. Whether the amount added is greater or less than this range, the effect of the divalent and trivalent iron salt is attenuated.
二価三価鉄塩を配合して本発明を突流できる化粧品とし
ては、化粧水、乳液、クリーム、パラ久化粧用油などの
基礎化粧品、シャンプー、ヘアトニック、育毛剤などの
頭髪用化粧品、及び口紅。Cosmetics to which the present invention can be applied by incorporating divalent and trivalent iron salts include basic cosmetics such as lotions, milky lotions, creams, and para-cosmetic oils, hair cosmetics such as shampoos, hair tonics, and hair growth agents; lipstick.
ファンデーシーン、頬紅などのメークアップ化粧品など
、はとんど全ての化粧品について適用が可能である。た
だし、化粧品の形状、均一分散性を考慮して、水溶性あ
るいは水分散性の担体、油分散性担体および粉末担体を
選択して使用することが必要である。It can be applied to almost all cosmetics, such as foundation cosmetics and makeup cosmetics such as blusher. However, it is necessary to select and use water-soluble or water-dispersible carriers, oil-dispersible carriers, and powder carriers in consideration of the shape and uniform dispersibility of the cosmetic product.
使用する化粧品のpHは8〜11の広範囲が適用可能で
あるが、pH5〜8が最も好ましいPR範囲である。The pH of the cosmetics used can range from 8 to 11, but the most preferred PR range is pH 5 to 8.
なお、本発明の化粧品には、通常の化粧品に配合使用さ
れる溶剤、油脂類、・界面活性剤、防腐剤。The cosmetics of the present invention include solvents, oils and fats, surfactants, and preservatives that are commonly used in cosmetics.
香料1色素カどが配合されるが、二価二価鉄塩の配合量
が極微量であるため、鉄塩と度広性のある千し−ト剤、
フェノール類、メルカプタン類、カチオン活性剤などが
原料として、あるいは不純物として混在した場合には、
本発明の二価三価鉄塩の効果を化粧品に付加することが
不能になるので事前に十分チエツクする必要がめる。The fragrance contains one colorant, but since the amount of divalent iron salt is extremely small, it is mixed with iron salt and a spreading agent.
If phenols, mercaptans, cation activators, etc. are mixed as raw materials or as impurities,
Since it will be impossible to add the effects of the divalent and trivalent iron salt of the present invention to cosmetics, it is necessary to thoroughly check in advance.
本発明の二価三価鉄塩によるイオン反応の阻止能力をチ
エツクする方法としては、パイオアフ七−法など種々の
方法が考えられるが、最も簡単な方法として次の方法が
上げられる。As a method for checking the ability of the divalent and trivalent iron salt of the present invention to inhibit ionic reactions, there are various methods such as the Pioaf method, but the following method is the simplest method.
化粧品のイオン反応阻止テストとしては、化粧品ベース
をそのまま、あるいは精製水で希釈するか、精製水で抽
出した水相部を試料として、試薬銅粉を適量加えて分散
させた後硝酸試液を添加すると、通常の化粧品の場合は
、当然銅粉と硝酸が反応して、H2ガスが発生し、液は
硝酸銅の生成によシ青色に呈色するが、二価三価鉄塩に
よシイオン反応阻止能力を持つ化粧品の場合は、液は無
色でH2ガスの発生も認められないが、これは銅粉の溶
解およびイオン反応力が進まないためと思われる。For the ion reaction inhibition test for cosmetics, use the cosmetic base as it is, dilute it with purified water, or use the aqueous phase extracted with purified water as a sample, add an appropriate amount of reagent copper powder, disperse it, and then add nitric acid test solution. In the case of ordinary cosmetics, copper powder and nitric acid naturally react, generating H2 gas and turning the liquid blue due to the formation of copper nitrate, but due to the ion reaction with divalent and trivalent iron salts. In the case of cosmetics with blocking ability, the liquid is colorless and no H2 gas is observed to be generated, but this is probably because the dissolution of the copper powder and the ionic reaction force do not progress.
同様に、化粧品原料の水溶液あるいは、不溶性原料では
精製水で抽出した液に、適量の二価三価鉄塩を加えて銅
イオンの呈色反応を行わせることにより、化粧品原料の
二価三価鉄塩適合性を検査することが可能である。Similarly, by adding an appropriate amount of divalent and trivalent iron salts to an aqueous solution of cosmetic raw materials or a solution extracted with purified water for insoluble raw materials to cause a color reaction of copper ions, the divalent and trivalent components of cosmetic raw materials can be extracted. It is possible to test iron salt compatibility.
以上の方法により、原料の二価三価鉄塩適合性を事前に
チエツクした後、化粧品を製造し、さらに製造された化
粧品について再度鋼イオン生成反応をチエツクすること
によシ得られた化粧品の二価三価鉄塩による効果を確認
することが出来る。By the above method, cosmetics are manufactured after checking the compatibility of the raw materials with divalent and trivalent iron salts, and the manufactured cosmetics are checked again for the steel ion generation reaction. The effect of divalent and trivalent iron salts can be confirmed.
以上のように本発明の=価玉価鉄塩配合の化粧品は、皮
膚に適用することにより、生体の機能を正常化させる作
用によって、次のような効果が認められる。As described above, when the cosmetics containing iron salts of the present invention are applied to the skin, the following effects are observed due to the action of normalizing the functions of the living body.
(11皮膚機能の増進
皮膚組織が本来持つている生理機能、すなわち表皮の正
常な角化代謝、皮脂分泌、および水分蒸散作用の正常化
による皮膚表面の状部のコントロール、さらには毛母細
胞および色素細胞の正常な代謝による毛髪の正常な発育
、色素の適正な分布など、本来生体が備えている皮膚の
正常化をそのまま促進させることができる。(11 Enhancement of skin functions) Control of the shape of the skin surface by normalizing the physiological functions of the skin tissue, normal keratinization metabolism of the epidermis, sebum secretion, and normalization of water evaporation; It is possible to directly promote the normalization of the skin that is naturally present in the body, such as normal hair growth due to normal metabolism of pigment cells and appropriate distribution of pigments.
(2)再生能力の強化
皮膚組織は本来代廁機能の不調や、外部環境に起因する
角質層の損傷や、皮脂、水分の過不足異常による皮膚表
面の悪化状態を正常化回復させる能力を持っているが、
本発明の化粧品を適用することによシ、この再生機能を
よシ速やかに強化回復させることができる。例えば、脱
毛の再生、白毛の黒化、炎症などの予後、あるい社、進
行性指掌角化症などの角質の異常亢進の正常化、色素沈
着によるシミの除去、ヒビ。(2) Enhancement of regenerative ability Skin tissue originally has the ability to normalize and recover from deterioration of the skin surface due to malfunctions in the regenerative function, damage to the stratum corneum caused by the external environment, and abnormalities in sebum and moisture levels. Although,
By applying the cosmetics of the present invention, this regeneration function can be strengthened and recovered more quickly. For example, regeneration of hair loss, darkening of white hair, prognosis of inflammation, normalization of hyperkeratin abnormalities such as progressive palmar keratosis, removal of spots due to pigmentation, and cracks.
アカギレなどの皮脂膜の不足に起因する表皮異常の回復
が速やかに達成される。Recovery from epidermal abnormalities caused by lack of sebum membrane, such as red rash, is quickly achieved.
(8)環境変化に対する適応性の増強
外部からの刺激物質、寒冷、熱暑および紫外線照射に対
する皮膚の適応力を強化して、皮膚本来の保護機能を保
持することができる。例えば、外部からの抗原物質の浸
入を抑制するととにより、感作性皮膚障害を防ぐことが
できる。(8) Enhancement of adaptability to environmental changes The adaptability of the skin to external stimulants, cold, heat, and ultraviolet irradiation can be strengthened to maintain the skin's original protective function. For example, by suppressing the infiltration of antigenic substances from the outside, sensitizing skin disorders can be prevented.
また外部環境に合わせて皮脂膜の形成を促進して、皮膚
を美しい状顧に保護することができる。In addition, it can promote the formation of a sebum film according to the external environment and protect the skin in a beautiful condition.
(4)微生物の異常増殖の阻止
外部からの付着微生物および皮膚常在菌の異常増殖によ
る炎症、化膿などの皮膚トラブルを除去、防止すること
ができる。例えば、ニキビ。(4) Prevention of abnormal growth of microorganisms Skin troubles such as inflammation and suppuration due to abnormal growth of microorganisms attached from the outside and bacteria resident on the skin can be removed and prevented. For example, acne.
ワキガ、被髪頭皮のフケ、カユミなど微生物の増殖に由
来する皮膚の異常を防止することができる。It can prevent skin abnormalities caused by the proliferation of microorganisms, such as armpit irritation, dandruff on the scalp, and itching.
また、二価三価鉄塩を配合することKよ)、化粧品に通
常配合される防腐剤も不要になシ。It also eliminates the need for preservatives that are normally added to cosmetics.
防腐剤に起因する感作性皮膚障害も防止することができ
る。Sensitized skin disorders caused by preservatives can also be prevented.
(5)有害イオン反応の阻止
外部からの化学物質による皮屑刺激反応および紫外線照
射による皮脂成分の過酸化脂質の形成など、有害イオン
反応および遊離基反応を抑制することによシ、皮膚の老
化、脱毛、白毛化などを防ぐことができる。(5) Inhibition of harmful ion reactions Suppressing harmful ion reactions and free radical reactions, such as skin irritation reactions caused by external chemicals and the formation of peroxidized lipids in sebum components caused by ultraviolet irradiation, reduces skin aging. , can prevent hair loss, hair graying, etc.
ま九二価ミ価鉄塩を配合すること忙よシ、油°脂類配合
化粧品の酸化変質を防止できるので、感作性皮膚障害の
原因になシやすい油脂の酸化防止剤も不要忙なる。By incorporating divalent iron salts, it is possible to prevent oxidative deterioration in cosmetics containing oils and fats, so there is no need for antioxidants for oils and fats, which tend to cause sensitized skin disorders. .
本発明にかかる化粧品は、各種配合成分による個々の化
粧品としての効能効果以外に、上記6項目の生体忙対し
て不可欠のメリットが見込める点において、従来の化粧
品には見られない非常に優れた効果を発揮することがで
きる。The cosmetics according to the present invention have extremely excellent effects not found in conventional cosmetics, in that, in addition to the efficacy and effect of individual cosmetics due to the various ingredients, they can be expected to have essential benefits for the six points listed above for the body's busyness. can demonstrate.
次に実施例および比較例をあげて、本発明の効果を具体
的に示すが、本発明はこの実施例に限定されるものでは
ない。Next, Examples and Comparative Examples will be given to concretely demonstrate the effects of the present invention, but the present invention is not limited to these Examples.
なお、以下の実施例における配合量は重量%である。In addition, the compounding amount in the following examples is weight %.
実施例1゜
化粧水
■エチルアルコール 5.0%■グリセ
リン 5.0%■ピロリドンカA
→’41ナトリウム液 0.5%−■ニラコ
ール ビフアミン 0.2%(日光ケミ
カル製アミノ酸混合物)
■香 料 、適 量@F@2
C1,−XH20C中性脂質担体’) 1(f”
91;(h、C1,、hシテ)■精製水を加えて全量1
00.0%とする。Example 1゜ Lotion■Ethyl alcohol 5.0%■Glycerin 5.0%■Pyrrolidonka A
→'41 Sodium liquid 0.5% - ■Niracol bifumin 0.2% (amino acid mixture manufactured by Nikko Chemical) ■Fragrance, appropriate amount @F@2
C1, -XH20C neutral lipid carrier') 1(f”
91; (h, C1,, h shite) ■ Add purified water to make a total of 1
00.0%.
製法
■に■〜■を加えて攪拌溶解し、これを濾過して化粧水
を得る。Add ① to ② to manufacturing method ②, stir and dissolve, and filter this to obtain a lotion.
比較例1゜
実施例1と同様の処方で、■二価三価鉄塩を除いた化粧
水を作る。Comparative Example 1゜A lotion was prepared using the same formulation as in Example 1, excluding the divalent and trivalent iron salts.
実施例と比較例の化粧水を、それぞれ試料として銅粉、
硝酸を加えてイオン化反応テストを行うと、比較例では
H2ガスが発生し、硝酸銅の青色の呈色反応がみられる
が、実施例では反応は進行せず、二価三価鉄塩によるイ
オン反応阻止効果のある化粧水であることが認められた
。Copper powder and copper powder were used as samples for the lotions of Examples and Comparative Examples, respectively.
When an ionization reaction test is performed by adding nitric acid, in the comparative example, H2 gas is generated and a blue coloring reaction of copper nitrate is observed, but in the example, the reaction does not proceed and ions due to divalent and trivalent iron salts are generated. It was recognized that this lotion has a reaction inhibiting effect.
モニター50名によるこの化粧水のパネルテストを行つ
た結果では、比較例に比して保湿効果が高く、乾燥肌の
著しい改善が見られた。The results of a panel test of this lotion by 50 monitors showed that it had a higher moisturizing effect than the comparative example and showed a significant improvement in dry skin.
突流例九
ミルキーローシーン
■流動パラフィン λG%■スクワラ
ン 8,0%■グリセリン
7.0%■ポリオキシエチレンモノス
テアレート1.0%■セスキオレイン酸ソルビタン
0.8%■カルボ中ジビジビニルポリマー
0.2%■水酸化カリウム 0
.1%■香 料 適量■Fe2
CJ5−XH,0(中性脂質担体) 1 ft
2X(FI!2’4 トL7 )[相]精製水を加えて
全量100.0%とする。Rush example 9 Milky low scene■Liquid paraffin λG%■Squalane 8,0%■Glycerin
7.0% ■ Polyoxyethylene monostearate 1.0% ■ Sorbitan sesquioleate
0.8%■ Carbo medium dividivinyl polymer
0.2% ■ Potassium hydroxide 0
.. 1%■Fragrance Appropriate amount■Fe2
CJ5-XH,0 (neutral lipid carrier) 1 ft
2X (FI!2'4 tL7) [Phase] Add purified water to make the total volume 100.0%.
製法
■を◎に分散させ、■を加えて中和し、さらに■を加え
均一に溶解、分散させたものを70℃に加熱し、これに
■〜■をフO℃に加温溶解した亀のを添加して乳化し、
ホモジナイザーで乳化粒子を整えた後、攪拌冷却し、4
0℃で■を加えた後、室温まで攪拌してミルキーローシ
ーンを得る。Production method ■Disperse ■ in ◎, add ■ to neutralize it, then add ■ to homogeneously dissolve and disperse the mixture, heat it to 70℃, and add ■ to ■ to it by heating and dissolving it at 0℃. Add and emulsify,
After preparing the emulsified particles with a homogenizer, stir and cool, and
After adding ■ at 0°C, stir to room temperature to obtain milky low sheen.
比較例え
実施例2と同様の処方、製法で■二価三価鉄塩を除いた
ミルキーローシーンヲ作る。Comparative Example: Using the same formulation and manufacturing method as in Example 2, ■Milky Low Sheen was prepared without the divalent and trivalent iron salts.
実施例、比較例のミル千−ローシ廖ンについて両者を酸
性にして油脂成分および遊離の樹脂成分を分離した水相
部について、銅粉、硝酸によるイオン化反応テストを行
うき、実施例のミルキーローシ・ンは銅イオンによる呈
色がなく、二価三価鉄地によるイオン反応阻止効果のあ
るミルキーローシーンであることが認められた。Regarding the Milky Roshe of Examples and Comparative Examples, an ionization reaction test with copper powder and nitric acid was conducted on the aqueous phase after acidifying both the oil and fat components and free resin components.・N was found to be a milky low sheen with no coloration due to copper ions and an ionic reaction inhibiting effect due to the divalent and trivalent iron base.
モニター50名によるパネルテストの結果、実施例のミ
ルキーローシーンは乾皮症などの乾燥性皮膚に対し、刺
激がなく、湿潤効果が高く、皮膚の乾燥状顧、掻痒感が
軽減された。As a result of a panel test conducted by 50 monitors, the Milky Low Sheen of the example was found to be non-irritating to dry skin such as xerosis, to have a high moisturizing effect, and to reduce dryness and itching of the skin.
実施例8゜
化粧クリーム
■ポリオキシエチレンモノステアレート 10
.0%■モノステアリン酸グリセリン 5.0
%■ミツロウ 1.0%■流動
パラフィン to%■シリコンオイル
4.0%■グリセリン
15.0%■アミノメチルプロパノール
0,2%■香料 適量
@F@8C1,−XH20C中性脂’JR担体)
1(r12X%Q!−吐ズ)■精製水を加えて全
量Zoo、0%とする。Example 8゜Cosmetic cream ■Polyoxyethylene monostearate 10
.. 0%■Glyceryl monostearate 5.0
%■Beeswax 1.0%■Liquid paraffin to%■Silicone oil 4.0%■Glycerin
15.0%■Aminomethylpropanol
0.2% ■Fragrance Appropriate amount @F@8C1, -XH20C Neutral fat 'JR carrier)
1 (r12X%Q!-vomit) ■ Add purified water to make the total volume Zoo, 0%.
製法
■〜■を70℃に加熱し、■、■、[相]をフO℃にて
加熱溶解した中に攪拌添加して乳化し、ホモジナイザー
で乳化粒子を整えた後、攪拌冷却し、40℃で■を加え
た後室r!Aまで冷却攪拌して化粧クリームを得る。Production methods ■~■ were heated to 70°C, and added to a solution of ■, ■, and [phase] heated and dissolved at 0°C to emulsify. After preparing emulsified particles with a homogenizer, stir and cool. After adding ■ at ℃ r! Cool and stir until A to obtain a cosmetic cream.
比較例8゜
実施例と同様の処決、製法で■二価三価鉄塩を除いた化
粧クリームを作る。Comparative Example 8゜A cosmetic cream was prepared using the same treatment and manufacturing method as in the example except for excluding divalent and trivalent iron salts.
実施例と比較例のクリームについて、酸性にして油脂成
分を分離した水相について銅粉、硝酸によるイオン化反
応テストを行うと、実施例のクリームに銅イオンによる
呈色がなく、二価三価鉄塩によるイオン反応阻止効果の
あるクリームであることが認められた。When we conducted an ionization reaction test with copper powder and nitric acid on the aqueous phase of the creams of Examples and Comparative Examples, which had been acidified to separate the oil and fat components, we found that the creams of Examples had no coloration due to copper ions, and showed no coloration due to copper ions. The cream was found to have the effect of inhibiting ion reactions caused by salt.
モニター50名によるパネルテストの結果、実施例の化
粧クリームは、アトピー性皮膚炎など炎症をもつ敏感肌
に塗擦しても刺激がなく、炎症部位の治癒が促進とれた
。As a result of a panel test conducted by 50 monitors, the cosmetic cream of the example did not cause irritation even when rubbed on sensitive skin with inflammation such as atopic dermatitis, and the healing of the inflamed area was promoted.
実施例4゜
化粧用油
■天然ビタミンE油 5.0%■α−ビ
サボロール 0.1%■オリブ油で全量
100.0%とする。Example 4 Cosmetic oil ■ Natural vitamin E oil 5.0% ■ α-bisabolol 0.1% ■ Olive oil makes the total amount 100.0%.
製法
■および■を■に加えて、溶解し、これに二価三価鉄塩
(中性脂質担体)iFg/j!水溶液10.0%を加え
てよく振産し、分離した水相を除去し、無水芒硝にて脱
水して化粧用油を得る。Production method ■ and ■ are added to ■, dissolved, and divalent and trivalent iron salt (neutral lipid carrier) iFg/j! Add a 10.0% aqueous solution, shake well, remove the separated aqueous phase, and dehydrate with anhydrous sodium sulfate to obtain a cosmetic oil.
比較例を
実施例4と同一処理で、二価三価鉄塩で振著処理を行わ
ない化粧油を作る。。As a comparative example, a cosmetic oil was prepared using the same treatment as in Example 4, but without the shaking treatment using divalent and trivalent iron salts. .
実施例、比較例ともに、同量のM製水を加えてよく振雀
し、分離した水相部について銅粉、硝酸によるイオン化
反応テストを行うと、実施例は鋼イオンの呈色がなく、
イオン反応が抑制されることが認められた。In both Examples and Comparative Examples, the same amount of M-made water was added and shaken well, and the separated aqueous phase was subjected to an ionization reaction test with copper powder and nitric acid.
It was observed that ionic reactions were suppressed.
モニター80名によるパネルテストの結果、乾皮症、掻
痒症の軽減および角質層の薄い部位、粘膜部位での微生
物に起因する異臭およびカニぐ、刺激の除去効果のある
ことが認められた。As a result of a panel test conducted by 80 monitors, it was found to be effective in alleviating xeroderma and pruritus, as well as removing foul odors, crabs, and irritation caused by microorganisms in areas with thin stratum corneum and mucous membranes.
実施例5゜
化粧用パック
■ポリビニルアルコール 15.0%■グリセ
リン 5.0%■水溶性ポリシロキ
サン共重合物 8.0%■エチレングリコール
1.0%モノステアレート
■F・8C718・XH20(中性脂質担体)
1 F’ 2X(F・8C18として)■香料
適量
■精製水を加えて全量100.0%とする。Example 5゜Cosmetic pack■Polyvinyl alcohol 15.0%■Glycerin 5.0%■Water-soluble polysiloxane copolymer 8.0%■Ethylene glycol
1.0% monostearate F・8C718・XH20 (neutral lipid carrier)
1 F' 2X (as F・8C18) ■Fragrance
Add an appropriate amount of purified water to make the total volume 100.0%.
製法
■に■および■を加えて加熱溶解させ、これに■〜■を
加熱溶解したものを加えて均一に混和し冷却し、40℃
以下で■を加えて攪拌し、室温まで冷却してパックを得
る。Add ■ and ■ to manufacturing method ■, heat and dissolve, add the heated melt of ■ to ■, mix uniformly, cool, and heat to 40℃.
Add (■) below, stir, and cool to room temperature to obtain a pack.
比較例5
実施例5と同一処方で、■二価三価鉄塩を配合しないパ
ックを作る。Comparative Example 5 A pack was made using the same formulation as in Example 5, but without the addition of divalent and trivalent iron salts.
実施例5、比較例のパックの10%水溶液について、銅
粉、硝酸によるイオン化反応テストを行うと、実施例は
銅イオンの呈色がなく、イオン反応が抑制されることが
認められた。When the 10% aqueous solutions of the packs of Example 5 and Comparative Example were subjected to an ionization reaction test using copper powder and nitric acid, it was found that there was no coloring of copper ions in Examples, and that the ionic reaction was suppressed.
モニター50名によるパネルテストの結果では乾性肌、
脂性肌の改善がみらり、炎症部、湿疹部位にも刺激がな
く治癒軽減効果が認められた。The results of a panel test conducted by 50 monitors showed that dry skin,
There was an improvement in oily skin, and there was no irritation in inflamed and eczema areas, and a healing effect was observed.
実施例6゜
シャンプー
■アルキル硫酸トリエタノールアミン液 20.
0%■ポリオキシエチレ/アルキルエーテル 2
5.0%硫酸ナトリウム液
■ヤシ油脂脂酸ジェタノールアミド 5.0
%■グリセリン 10.0%■香
料 適 量@F@、(J、、X
H2O(4化す) IJ 、7ム担体) ltr”%5
’hf:16として)■精製水を加えて全量100.0
%とする。Example 6゜Shampoo ■Alkyl sulfate triethanolamine solution 20.
0%■Polyoxyethylene/alkyl ether 2
5.0% sodium sulfate solution■ Coconut oil fatty acid jetanolamide 5.0
%■Glycerin 10.0%■Fragrance
Appropriate amount @F@, (J,,X
H2O (4) IJ, 7M carrier) ltr”%5
'hf: 16) ■ Add purified water to total volume 100.0
%.
製法
■に■〜■を順次加えて加温溶解してシャンプーを得る
。Add ① to ② in order to manufacturing method ② and heat and dissolve to obtain shampoo.
比較例6゜
実施例6と同一処方で、■二価三価鉄塩を除いたシャン
プーを作る。Comparative Example 6゜A shampoo is made using the same formulation as in Example 6, except that ■ divalent and trivalent iron salts are excluded.
両者の10%水溶液について、銅粉、硝酸によるイオン
化反応テストを行うと、実施例は銅イオンの呈色がなく
、イオン反応が抑制されることが認められた。When an ionization reaction test using copper powder and nitric acid was performed on a 10% aqueous solution of both, it was found that in the example, there was no coloration of copper ions, and the ionic reaction was suppressed.
モニター50名による8ケ月間の継続使用テストの結果
、通常の洗髪回数で明らかにフケ、カユミの発生の軽減
が認められた。As a result of an 8-month continuous use test conducted by 50 monitors, a clear reduction in the occurrence of dandruff and itching was observed with regular hair washing.
実施例?。Example? .
ヘアトニック
■エタノール 65.ON’■レゾ
ルシン 0.1%■トウガラシテ
ン千 5.0%■!−メントール
0.5%■グリセリン
5.0%■ポリオキシエチレンモノステアレート
2.0%■香料 適量
■F・2C16α弁P(中性脂質担体) 11〜
(”2’4として)■精製水を加えて全量100.0%
とする。Hair tonic■Ethanol 65. ON'■Resorcinol 0.1%■Capsicum 5.0%■! −Menthol
0.5% ■ Glycerin
5.0% ■ Polyoxyethylene monostearate
2.0%■Fragrance Appropriate amount■F・2C16α valve P (neutral lipid carrier) 11~
(As ``2'4'') ■Add purified water to make 100.0% total amount
shall be.
製法
■に■〜■を順次加えて加温溶解し、冷却後濾過してヘ
アトニックを得る。Add (1) to (2) in sequence to Production Method (2), heat and dissolve, cool and filter to obtain a hair tonic.
比較例7゜
実施例7と同一処方で、■二価三価鉄塩を配合しないヘ
アトニックを作る。Comparative Example 7゜A hair tonic was prepared using the same formulation as in Example 7, but without the addition of divalent and trivalent iron salts.
両者について銅粉、硝酸によるイオン化反応テストを行
うと、実施例では銅イオンの呈色を見ずイオン反応が抑
制されることが認められた。When an ionization reaction test using copper powder and nitric acid was performed on both samples, it was confirmed that the ion reaction was suppressed without any coloration of copper ions observed in the example.
モニター50名による6ケ月間の長期継続使用テストで
80名について明らかに脱毛の減少、育毛効果およびフ
ケ、カユミの軽減が認められた。In a 6-month long-term continuous use test conducted by 50 monitors, 80 people found a clear reduction in hair loss, a hair growth effect, and a reduction in dandruff and itching.
実施例8゜
ファンデーシーン
■酸化チタン 5.0%■マイカ
50.0%■タルク
20.0%■ステアリ糧アルアルミ
ニウム 5.0%■無水ケイ酸
6.0%■フィトステロール
20%■ポリオキシエチレンモノステアレート
0.5%■シリコンオイル
7.0%■ワセリン 8.
5%■無機顔料 適量■香 料
適量@ F@ 2C1,−X
H,O(中性能[担体) 11”J、(σす4と
して)製法
■〜■および0を混合し、加熱溶融した■〜■および■
、■を加えて十分に混合し、これを全血にプレスしてフ
ァンデーシーンを得る。Example 8゜Foundation scene■Titanium oxide 5.0%■Mica 50.0%■Talc
20.0% ■ Stear food Aluminum 5.0% ■ Silicic anhydride
6.0% ■ Phytosterol
20% ■ Polyoxyethylene monostearate
0.5%■Silicone oil
7.0% ■Vaseline 8.
5% ■ Inorganic pigment appropriate amount ■ Fragrance appropriate amount @ F @ 2C1, -X
H, O (medium performance [carrier)] 11"J, (as σS 4) Manufacturing method ■ ~ ■ and 0 were mixed and heated and melted ■ ~ ■ and ■
, ■, mix thoroughly, and press this into whole blood to obtain foundation sheen.
比較例8゜
実施例8と同一処方で、■=価玉価鉄塩を除いたファン
デージ雪ンを作る。Comparative Example 8゜Foundage Yukin was prepared using the same recipe as in Example 8 except that ■ = iron salt was excluded.
両者を精製水で抽出した水相部につき銅粉、硝酸による
イオン化反応テストを行うと、実施例では銅イオンの呈
色を見ず、イオン反応が抑制されることが認められた。When an ionization reaction test using copper powder and nitric acid was performed on the aqueous phase obtained by extracting both with purified water, no coloration of copper ions was observed in the example, and it was recognized that the ion reaction was suppressed.
敏感肌のモニター80名によるパネルテストの結果、実
施例のファンデーシーンは皮膚に対する刺激性はモニタ
ー全員が感じられず、化粧の持ちも改善されることが認
められた。As a result of a panel test conducted by 80 monitors with sensitive skin, none of the monitors felt that the Foundation Sheen of the Example was irritating to the skin, and it was observed that the longevity of makeup was improved.
実施例9゜
口 紅
■カルナウバロウ 10.0%■キャン
デリラロウ 5.0%■セタノール
5.0%■フィトステロール
10.0%■スクワラン
10.0%■顔 料 適 量
■香 料 適 量■ヒマシ油を
加えて全量100.0%とする。Example 9゜Lipstick■Carnauba wax 10.0%■Candelilla wax 5.0%■Setanol
5.0% ■ Phytosterol
10.0% ■ Squalane
10.0% ■ Pigment appropriate amount ■ Fragrance appropriate amount ■ Add castor oil to make the total amount 100.0%.
製法
ヒマy 油f F*2CJ5 ・XH2O(中性脂肪J
ii 体)If”g/j水溶液(F@、C4,として)
10%を加えて振蚤し、分離した水相を除去し、無水芒
硝で脱水処理したヒマシ油に■〜■を加えて加熱溶解し
、型に流し込んで冷却固化して口紅を得る。Manufacturing method castor oil f F*2CJ5 ・XH2O (neutral fat J
ii body) If”g/j aqueous solution (as F@, C4,)
10% is added and shaken, the separated aqueous phase is removed, and 1 to 2 are added to castor oil dehydrated with anhydrous sodium sulfate, dissolved by heating, poured into a mold, cooled and solidified to obtain a lipstick.
比較例9゜
二価三価鉄塩で処理しないヒマシ油を使用して実施例9
と同一処方で口紅を作る。Comparative Example 9 Example 9 using castor oil not treated with divalent and trivalent iron salts
Make lipstick using the same formula.
両者を同量の精製水で加熱処理後冷却した水相部につい
て、銅粉、硝酸によるイオン化反応テストを行つたとこ
ろ、実施例では銅イオンの呈色がなく、イオン反応の抑
制を認めた。When an ionization reaction test using copper powder and nitric acid was performed on the aqueous phase portion of both samples, which were heat-treated with the same amount of purified water and then cooled, there was no coloration of copper ions in the example, and it was confirmed that the ionic reaction was suppressed.
女性モニター50名によるパネルテストの結果では、刺
激がなく、乾燥しがちの口溝表面の状態が非常に改善さ
れた。The results of a panel test conducted by 50 female monitors showed that there was no irritation and the condition of the oral cavity surface, which tends to dry, was greatly improved.
特許出願人 有限会社 アイ・ビー・イー代 理 人 宇 佐 見 忠 男Patent applicant: IBM Ltd. Reason Man u Sa look Tadashi Man
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20789188A JP2694756B2 (en) | 1988-08-19 | 1988-08-19 | Cosmetics containing divalent and trivalent iron salts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20789188A JP2694756B2 (en) | 1988-08-19 | 1988-08-19 | Cosmetics containing divalent and trivalent iron salts |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0256409A true JPH0256409A (en) | 1990-02-26 |
JP2694756B2 JP2694756B2 (en) | 1997-12-24 |
Family
ID=16547280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20789188A Expired - Fee Related JP2694756B2 (en) | 1988-08-19 | 1988-08-19 | Cosmetics containing divalent and trivalent iron salts |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2694756B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02108612A (en) * | 1988-10-19 | 1990-04-20 | Shizen:Kk | Divalent and trivalent complex iron salt-compounded cosmetic |
WO2001093879A1 (en) * | 2000-06-06 | 2001-12-13 | I.B.E. Co., Ltd. | Biologically active agents and drugs |
JP2002265995A (en) * | 2001-03-08 | 2002-09-18 | Shizuko Watanabe | Soap |
WO2007078009A1 (en) * | 2006-01-06 | 2007-07-12 | Atom Japan, Inc. | Cosmetic |
JP2008016659A (en) * | 2006-07-06 | 2008-01-24 | Hitachi Ltd | Permanent current switch, its manufacturing apparatus, and method therefor |
JP2008214204A (en) * | 2007-02-28 | 2008-09-18 | Atomu Japan:Kk | Hair growth tonic |
US9333156B2 (en) | 2005-04-28 | 2016-05-10 | Sbi Pharmaceuticals Co., Ltd. | External preparation for skin |
-
1988
- 1988-08-19 JP JP20789188A patent/JP2694756B2/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02108612A (en) * | 1988-10-19 | 1990-04-20 | Shizen:Kk | Divalent and trivalent complex iron salt-compounded cosmetic |
WO2001093879A1 (en) * | 2000-06-06 | 2001-12-13 | I.B.E. Co., Ltd. | Biologically active agents and drugs |
AU2001262699B2 (en) * | 2000-06-06 | 2006-05-04 | I.B.E. Co., Ltd. | Biologically active agents and drugs |
US8377483B2 (en) * | 2000-06-06 | 2013-02-19 | I.B.E. Co., Ltd. | Biologically active agents and drugs |
JP2002265995A (en) * | 2001-03-08 | 2002-09-18 | Shizuko Watanabe | Soap |
US9333156B2 (en) | 2005-04-28 | 2016-05-10 | Sbi Pharmaceuticals Co., Ltd. | External preparation for skin |
WO2007078009A1 (en) * | 2006-01-06 | 2007-07-12 | Atom Japan, Inc. | Cosmetic |
JP2008016659A (en) * | 2006-07-06 | 2008-01-24 | Hitachi Ltd | Permanent current switch, its manufacturing apparatus, and method therefor |
JP2008214204A (en) * | 2007-02-28 | 2008-09-18 | Atomu Japan:Kk | Hair growth tonic |
Also Published As
Publication number | Publication date |
---|---|
JP2694756B2 (en) | 1997-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0770392B1 (en) | Use of manganese, yttrium or certain lanthanides salts in a cosmetic, dermatological or pharmaceutical composition to treat in particular sensitive skins | |
WO1997048371A1 (en) | Topical product formulations containing strontium for reducing skin irritation | |
JP2008127328A (en) | Cosmetic product and extract included therein | |
JPS63192705A (en) | External agent for skin | |
JPS6248611A (en) | External preparation for skin | |
JP5766258B2 (en) | Pigmentation preventing or improving agent | |
JPH08325130A (en) | Cosmetic | |
JPH0256409A (en) | Cosmetic containing bi-and trivalent iron salt blended therein | |
JP2002003358A (en) | Skin care preparation | |
JPH02108612A (en) | Divalent and trivalent complex iron salt-compounded cosmetic | |
JPH11269034A (en) | Skin prepafation for external use for improving acne | |
JP4887050B2 (en) | Inadequate keratinization inhibitor, pore reducing agent | |
JPH0840824A (en) | Cosmetic | |
CN109745262B (en) | Composition for whitening spot-fading face cream | |
JPH08133948A (en) | Skin preparation for external use | |
JPH08133950A (en) | Skin preparation for external use | |
JPH107582A (en) | Skin lotion | |
JP2855274B2 (en) | Hair restoration | |
JPS60116616A (en) | Cosmetic | |
JPH02145507A (en) | Dandruff preventing cosmetic | |
JP5144048B2 (en) | Radical scavenger, antioxidant skin external preparation, and radical scavenging method | |
JPS6396116A (en) | Hair cosmetic | |
JPH1179935A (en) | Anti-pigmentation agent, bleaching agent, and skin lotion for bleaching | |
JPH08133949A (en) | Skin preparation for external use | |
JP3615557B2 (en) | Anti-pigmentation agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |